Correlation Between Aeterna Zentaris and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aeterna Zentaris and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aeterna Zentaris and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aeterna Zentaris and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Aeterna Zentaris and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aeterna Zentaris with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aeterna Zentaris and Reviva Pharmaceuticals.
Diversification Opportunities for Aeterna Zentaris and Reviva Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Aeterna and Reviva is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Aeterna Zentaris and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Aeterna Zentaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aeterna Zentaris are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Aeterna Zentaris i.e., Aeterna Zentaris and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aeterna Zentaris and Reviva Pharmaceuticals
If you would invest 112.00 in Reviva Pharmaceuticals Holdings on September 1, 2024 and sell it today you would earn a total of 12.00 from holding Reviva Pharmaceuticals Holdings or generate 10.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Aeterna Zentaris vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Aeterna Zentaris |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Reviva Pharmaceuticals |
Aeterna Zentaris and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aeterna Zentaris and Reviva Pharmaceuticals
The main advantage of trading using opposite Aeterna Zentaris and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aeterna Zentaris position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Aeterna Zentaris vs. Pulmatrix | Aeterna Zentaris vs. Bio Path Holdings | Aeterna Zentaris vs. Moleculin Biotech | Aeterna Zentaris vs. Adial Pharmaceuticals |
| Reviva Pharmaceuticals vs. Tff Pharmaceuticals | Reviva Pharmaceuticals vs. Eliem Therapeutics | Reviva Pharmaceuticals vs. Inhibrx | Reviva Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |